drugset / Trial / NCT06181682

Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

NCT06181682 ↗

Phase 4 Unknown 70 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindSupportive care

Summary

compare the effectiveness of intranasal dexmedetomidine and midazolam as a premedication in sedation of preschool children in GI endoscopy

Timeline

Start
2024-01
Primary completion
2024-03
Completion
2024-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intranasal
Comparator Midazolam Small molecule 0.2 mg/kg Intranasal

Indications

No indication recorded.